Efficacy and Safety of Add-On Plant-Based Drugs for COVID-19 Patients: A Review of the Randomized Control Trials
Ajeng Diantini,1,* R Maya Febriyanti,2,* Jutti Levita1,* 1Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Padjadjaran University, Sumedang, West Java, 46363, Indonesia; 2Department of Biology Pharmacy, Faculty of Pharmacy, Padjadjaran University, Sumeda...
Main Authors: | Diantini A, Febriyanti RM, Levita J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-06-01
|
Series: | Infection and Drug Resistance |
Subjects: | |
Online Access: | https://www.dovepress.com/efficacy-and-safety-of-add-on-plant-based-drugs-for-covid-19-patients--peer-reviewed-fulltext-article-IDR |
Similar Items
-
The Prospect of Repurposing Immunomodulatory Drugs for Adjunctive Chemotherapy against Tuberculosis: A Critical Review
by: Chiyun Lee, et al.
Published: (2021-01-01) -
Eslicarbazepine acetate: An efficacy and safety as an antiepileptic drug in clinical trials and open studies
by: Martyna Stefaniak, et al.
Published: (2022-02-01) -
An evidence-based review of Morinda citrifolia L. (Rubiaceae) fruits on animal models, human studies, and case reports
by: Asman Sadino, et al.
Published: (2024-05-01) -
Does the Addition of Melatonin to Quadruple Therapy Increases the Eradication Rate of Helicobacter pylori? A Double-Blind Randomized Clinical Trial
by: Saeed Abdi, et al.
Published: (2018-05-01) -
Perampanel as first add-on antiseizure medication: Italian consensus clinical practice statements
by: Paolo Bonanni, et al.
Published: (2021-10-01)